Source disclosure: February 10, 2026
KANEKA CORPORATION [4118.T]
TOKYO, Feb 10 (Pulse News Wire) -- KANEDA CORPORATION (4118.T), a leading materials and life sciences company, reported its consolidated earnings for the third quarter ending December 31, 2025. The company recorded a sales revenue of ¥5,983 billion, marking no change compared to the same period last year. However, operating income declined by 23.8%, while net income increased by 4.0%.
Kaneda's performance was driven by several key factors. Sales remained stable due to continued expansion in the Medical sector, which has been a significant contributor to overall profitability. Conversely, the decline in operating income was attributed to challenging market conditions in Asia affecting the Vinyls division and prolonged low demand for residential and construction needs in the United States impacting the MOD and MS divisions. Additionally, slower-than-expected recovery in the Electronics and Industrial Materials (E&I) segment contributed to the reduced operating profit.
Notably, the company saw an increase in net income primarily due to progress in reducing policy-held equity investments, resulting in a cumulative sale gain of ¥102 billion during the three quarters. This strategic move significantly bolstered the bottom line despite the operational challenges faced across various segments.
In terms of product development, Kaneda highlighted several achievements. Its Green Planet biodegradable synthetic turf, co-developed with Mizuno, received the prestigious Nikkei Excellent Product and Service Award Grand Prize. The innovative material was first adopted at the Vantelin Dome Nagoya stadium. Furthermore, the company’s perovskite solar cell technology was selected for the New Energy and Industrial Technology Development Organization (NEDO)'s Green Innovation Fund project aimed at demonstrating next-generation tandem solar cell mass production technologies.
Looking ahead, Kaneda expects mixed results in the fourth quarter. While it anticipates ongoing growth in high-value products within the Performance Polymers division and steady improvements in Foam and PV sectors, it remains cautious about the extended downturn in Asian markets and sluggish U.S. housing and construction demands. The Health Care Solutions unit is expected to maintain strong momentum, particularly in medical devices, with new plant constructions progressing as planned.
Overall, Kaneda Corporation continues to navigate through fluctuating market dynamics, leveraging its robust portfolio of solutions units and focusing on sustainable innovations to drive future growth. The company's diversified approach aims to mitigate risks associated with volatile economic environments and capitalize on emerging opportunities in both domestic and international markets.